PDK2 Antibodies

Santa Cruz Biotechnology features a diverse variety of PDK2 monoclonal antibodies for advanced research in cellular metabolism and signaling. PDK2 Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PDK2, or Pyruvate Dehydrogenase Kinase 2, plays a crucial role in regulating the pyruvate dehydrogenase complex, which is essential for converting pyruvate into acetyl-CoA, a key metabolic intermediate. By modulating this pathway, PDK2 influences energy production and metabolic flexibility, making it a significant player in various physiological processes and disease states, including cancer and diabetes. Understanding PDK2 function is vital for developing targeted therapies and advancing metabolic research. PDK2 monoclonal antibodies enable researchers to explore cellular metabolism regulation in detail. Investigating PDK2's role in disease progression helps identify potential therapeutic targets for metabolic disorders. PDK2 research contributes to understanding energy metabolism in both normal and pathological conditions. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of metabolic pathways and potential therapeutic interventions.